Transferrin (Tf) and soluble
transferrin receptors (S-Tf-R) were measured by
enzyme immunoassay in seminal plasma of 130 semen samples. The mean concentration of S-Tf-R in cases with normozoospermia was 10.4 IU/ml (95% confidence interval: 9.5-11.3) and it was significantly lower in patients with
oligozoospermia (6.6, 95% CI: 5.8-7.5, P < 0.001),
asthenozoospermia (8.5, 95% CI: 5.5-10.7, P < 0.05),
azoospermia of primary testicular origin (7.9, 95% CI: 6.1-9.6, P<0.05) and post-
vasectomy samples (5.9, 95% CI: 5.4-6.9, P < 0.001). The concentration of S-Tf-R in post-
vasectomy samples was lower than that in patients with
azoospermia of primary testicular origin (P < 0.05; positive likelihood ration = 7 at value of 8.3 IU/ ml). S-Tf-R was positively correlated with motile sperm concentration (r = 0.50, P < 0.0001), percentage motility (r = 0.38, P < 0.001), percentage of normal forms (r = 0.43, P < 0.001), sperm linear velocity (r = 0.42, P < 0.001), and
ATP concentration (r = 0.67, P < 0.0001).
Follicle stimulating hormone (FSH) was found to be negatively correlated with the concentrations of both Tf (r = -0.31, P < 0.05) and of S-Tf-R (r = -0.45, P < 0.01). The mean concentration of Tf in seminal plasma was 50.4 micrograms/ml (35.9-67.2) in samples with normozoospermia (n = 22), and the concentration was significantly lower in patients with
oligozoospermia (P < 0.05),
azoospermia of testicular origin (P < 0.001), and post-
vasectomy samples (P < 0.001). Seminal Tf was correlated with motile sperm concentration (r = 0.36, P < 0.001), percentage of motile spermatozoa (r = 0.25, P < 0.05), linear velocity (r = 0.24, P < 0.05) and
ATP concentration (r = p.44, P < 0.001). The concentration of Tf was positively correlated with that of S-Tf-R both in cases with spermatozoa present (r = 0.66, P < 0.001), and in cases with
azoospermia of testicular origin (r = 0.51, P < 0.05) but not in
vasectomy cases. It is concluded that S-Tf-R in seminal plasma is a marker of spermatogenesis and may give information on the presence or absence of spermatogenetic cells in cases with
azoospermia. Further investigations are needed to assess its usefulness for clinical practice.